Advances in Cardiovascular Risk Reduction

Thursday, May 11, 2017, 6:00 AM - 11:59 PM (UTC-5:00) Eastern Time (US & Canada)

This one-day course will cover state-of-the-art management of patients with cardiovascular risk factors, with a focus on prevention. The morning session will focus on the latest scientific and clinical advances in the management of diabetes. In addition, the release of updated guidelines in diabetes management will provide state-of-the-art principles that will guide presentations and discussions throughout the morning session. Topics will include recent technological advances in diabetic care, a new algorithm for choice of therapies for T2DM and the management of inpatient diabetics. The role of diabetes nurses and their impact on a medical practice will also be presented. The afternoon session will include an update on platelets, PCSK9, APO C3 and triglycerides. Current strategies for atherosclerosis imaging will be reviewed as well as the clinical management of resistant hypertension.

Each year this course includes a research-oriented presentation that highlights bench-to-bedside relevance. This year the featured research-oriented presentation will focus on the latest research in diabetes expanding our understanding of this complex disease.

Ten (10) half-hour presentations will be given. Attendees will participate in a lunchtime hour-long case conference with challenging cases in cardiovascular disease risk reduction. Course participants are given the opportunity to submit questions to the featured speakers and panel members. The course will include morning and afternoon panel discussion segments (45 min each) in which the questions from the audience are answered and debated among expert panel members.

Location

NYU Langone Medical Center
550 First Avenue
Alumni Hall, Farkas Auditorium
New York, NY 10016

Tag